Recent news and posts
Three more health apps obtained reimbursement in Germany
In late April – and early May 2021, three more reimbursable health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, fifteen health apps are now available at the DiGA Directory.
The health app "Mindable: Panic Disorder and Agoraphobia" (Mindable Health GmbH, Germany) is based on the methods of cognitive behavioral therapy (CBT) and supports users in proactively addressing and reducing their fears. Mindable is available in German, English, and French with a tariff of €576.
"CANKADO PRO-React Onco" (CANKADO Service GmbH, Germany) is indicated in breast cancer and supports patients under systemic, anti-tumor, or anti-hormonal therapy in an adjuvant, neoadjuvant, post-neoadjuvant, or palliative treatment modes. With PRO-React Onco, patients can record their complaints and receive tailored behavior recommendations. The app is available in 14 languages with a tariff of €499.80.
The third newly introduced health app, "vorvida" (GAIA AG, Germany), is an online platform that helps users manage their drinking behavior and reduce alcohol consumption. vorvida is indicated in mental and behavioral disorders due to alcohol use and is based on established psychotherapeutic approaches and procedures, especially CBT. The app is available in German and English with a tariff of €476.
The full details in German can be found here.
This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).
Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.